Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
In This Section
More Information
Health in the Landscape of Life
Enabling the healthscape, the ecosystem outside the clinic, requires improving the system to pay for health drivers.
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Give Faculty Students Directory

Laura Q.M. Chow, M.D., FRCPC

UT Health Austin Care Team Member

University of British Columbia; Vancouver, British Columbia


Residency, Internal Medicine
University of Alberta; Edmonton, Alberta

Fellowship, Medical Oncology
University of Calgary, Tom Baker Cancer Center; Calgary, Alberta


Laura Chow is a professor of oncology with tenure and the associate chair of education in the Department of Oncology at Dell Medical School. She is also director of thoracic, head and neck malignancies and clinical immunotherapy programs and the associate director of clinical research at Livestrong Cancer Institutes.

Previously, Chow spent more than nine years as the associate director of the phase I developmental therapeutics program and attending medical oncologist in lung, head and neck malignancies at Seattle Cancer Care Alliance; associate member of clinical research at the Fred Hutchinson Cancer Research Center; and a professor in the Department of Medicine, Division of Oncology at the University of Washington.

Chow came to medicine with a background in pharmacology and therapeutics and was inspired to pursue a career in oncology because of her personal experiences with cancer in her family as well as her interest in clinical research.

Chow has extensive clinical trials experience; a strong background in clinical pharmacology, therapeutics and developmental therapeutics; and excellent Canadian and USA internal medicine and clinical medical oncology skills and training. Her clinical expertise is in head and neck cancers, thyroid cancer and lung cancers with a national and international reputation as a researcher focused on novel therapeutics and early phase clinical trials, immunotherapy and head and neck cancers, thyroid cancers and lung cancers. She has helped develop and bring forth many novel drugs, including the PD-1 immune-checkpoint inhibitors, into regulatory approval as standard-of-care treatments for head and neck cancers and lung cancer. She has been the lead principal investigator of over 40 early phase thoracic and head and neck cancer trials with over 65 publications in high-impact journals, with a clinical research interest focused on developing novel lung and head and neck cancer immune-checkpoint therapies and new combination immunotherapeutics.

Chow enjoys teaching and believes strongly in patient-centered clinical care. In addition to English, she is fluent in Cantonese and conversational French. In her spare time, she runs, cycles, pursues fitness classes, cooks, bakes and loves spending time with her husband and 5-year-old son.

Professional Affiliations
  • American Society of Clinical Oncology
  • American Association of Clinical Research
  • National Cancer Institute
  • NCI Cancer Immunotherapy Trials Network
  • NCI Investigational New Drug Task Force/Working Group
Awards & Honors
  • Development Therapeutics/Research & Development Award
    Canadian Association of Medical Oncologists, 2004-2006